[SCHEDULE 13G] Semler Scientific, Inc. SEC Filing
Citadel-related entities and Kenneth Griffin report beneficial ownership of Semler Scientific (SMLR) common stock totaling approximately 697,427 shares, representing 5.1% of the class. The filing is a joint Schedule 13G covering Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, and Kenneth Griffin. Ownership totals per entity range from 570 shares to 697,997 shares for Mr. Griffin. The groups report no sole voting or dispositive power; all reported voting and dispositive power is shared. The percentages are calculated on 13,688,405 shares outstanding as of June 30, 2025.
Entità collegate a Citadel e Kenneth Griffin dichiarano titolarità effettiva di azioni ordinarie Semler Scientific (SMLR) per circa 697.427 azioni, pari al 5,1% della classe. La comunicazione è un Schedule 13G congiunto che riguarda Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC e Kenneth Griffin. Le partecipazioni per singola entità variano da 570 azioni a 697.997 azioni per il sig. Griffin. I gruppi dichiarano di avere nessun potere di voto o dispositive esclusivo; tutto il potere di voto e dispositive segnalato è condiviso. Le percentuali sono calcolate su 13.688.405 azioni in circolazione al 30 giugno 2025.
Entidades relacionadas con Citadel y Kenneth Griffin informan la propiedad beneficiaria de acciones ordinarias de Semler Scientific (SMLR) por un total aproximado de 697.427 acciones, que representan el 5,1% de la clase. La presentación es un Schedule 13G conjunto que abarca a Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC y Kenneth Griffin. Las tenencias por entidad oscilan entre 570 acciones y 697.997 acciones en el caso del Sr. Griffin. Los grupos informan no tener poder exclusivo de voto ni dispositvo; todo el poder de voto y dispositvo declarado es compartido. Los porcentajes se calculan sobre 13.688.405 acciones en circulación al 30 de junio de 2025.
Citadel 관련 법인들과 Kenneth Griffin은 Semler Scientific(SMLR) 보통주 총 약 697,427주(해당 등급의 5.1%)에 대한 실질적 소유를 보고했습니다. 해당 제출서는 Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC 및 Kenneth Griffin을 포함한 공동 Schedule 13G입니다. 개별 법인별 보유량은 570주에서 Griffin 씨의 697,997주까지 다양합니다. 그룹들은 단독 의결권이나 처분권이 없음을 보고했으며; 보고된 모든 의결권 및 처분권은 공유됩니다. 비율은 2025년 6월 30일 기준 발행주식 13,688,405주를 기준으로 산정되었습니다.
Des entités liées à Citadel et Kenneth Griffin déclarent la propriété bénéficiaire d'actions ordinaires de Semler Scientific (SMLR) totalisant environ 697 427 actions, soit 5,1% de la catégorie. Le dépôt est un Schedule 13G conjoint couvrant Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC et Kenneth Griffin. Les détentions par entité vont de 570 actions à 697 997 actions pour M. Griffin. Les groupes déclarent ne détenir aucun pouvoir de vote ou de disposition exclusif ; tous les pouvoirs de vote et de disposition déclarés sont partagés. Les pourcentages sont calculés sur 13 688 405 actions en circulation au 30 juin 2025.
Citadel-nahe Einheiten und Kenneth Griffin melden wirtschaftliches Eigentum an Semler Scientific (SMLR) Stammaktien in Höhe von insgesamt rund 697.427 Aktien, was 5,1% der Klasse entspricht. Die Meldung ist ein gemeinsames Schedule 13G, das Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC und Kenneth Griffin umfasst. Die Bestände je Einheit reichen von 570 Aktien bis zu 697.997 Aktien bei Herrn Griffin. Die Gruppen geben an, keine alleinige Stimm- oder Verfügungsmacht zu haben; alle gemeldeten Stimm- und Verfügungsmachten sind geteilt. Die Prozentsätze wurden auf Grundlage von 13.688.405 ausstehenden Aktien zum 30. Juni 2025 berechnet.
- Material institutional disclosure: Citadel-related reporting persons disclose a combined 5.1% stake, meeting SEC transparency thresholds
- Clarity on holdings: Filing provides exact share counts and the share-outstanding basis (13,688,405) used to calculate percentages
- No sole voting or dispositive power: All reported authority is shared, indicating limited unilateral governance influence
- Passive filing (13G): The statement indicates holdings are reported as passive rather than an active intent to change control
Insights
TL;DR: Citadel-linked parties disclose a >5% passive stake in SMLR, indicating a notable institutional position without sole control.
The joint Schedule 13G shows institutional accumulation equivalent to 5.1% of Semler Scientific's outstanding common stock. For investors, a >5% passive filing signals that sizeable liquidity and trading flows may be associated with these desks and funds. The filing discloses shared voting and dispositive power rather than sole control, consistent with passive or investment-management positions rather than an activist intent. The base of 13,688,405 shares outstanding provides the context for the 5.1% figure. This is material ownership disclosure but does not change governance dynamics given the lack of sole control.
TL;DR: Ownership crosses the 5% disclosure threshold but shows no unilateral control; governance impact appears limited.
The Schedule 13G identifies multiple affiliated reporting persons and shows shared voting and dispositive power across Citadel entities and Mr. Griffin. Because the filing is a 13G rather than a 13D and indicates shared rather than sole authority, it reflects a passive or investment-management position rather than a coordinated effort to influence corporate control. From a governance standpoint, this means Semler Scientific should note the institutional holder but does not face an immediate change in control or activist pressure based on this filing alone.
Entità collegate a Citadel e Kenneth Griffin dichiarano titolarità effettiva di azioni ordinarie Semler Scientific (SMLR) per circa 697.427 azioni, pari al 5,1% della classe. La comunicazione è un Schedule 13G congiunto che riguarda Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC e Kenneth Griffin. Le partecipazioni per singola entità variano da 570 azioni a 697.997 azioni per il sig. Griffin. I gruppi dichiarano di avere nessun potere di voto o dispositive esclusivo; tutto il potere di voto e dispositive segnalato è condiviso. Le percentuali sono calcolate su 13.688.405 azioni in circolazione al 30 giugno 2025.
Entidades relacionadas con Citadel y Kenneth Griffin informan la propiedad beneficiaria de acciones ordinarias de Semler Scientific (SMLR) por un total aproximado de 697.427 acciones, que representan el 5,1% de la clase. La presentación es un Schedule 13G conjunto que abarca a Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC y Kenneth Griffin. Las tenencias por entidad oscilan entre 570 acciones y 697.997 acciones en el caso del Sr. Griffin. Los grupos informan no tener poder exclusivo de voto ni dispositvo; todo el poder de voto y dispositvo declarado es compartido. Los porcentajes se calculan sobre 13.688.405 acciones en circulación al 30 de junio de 2025.
Citadel 관련 법인들과 Kenneth Griffin은 Semler Scientific(SMLR) 보통주 총 약 697,427주(해당 등급의 5.1%)에 대한 실질적 소유를 보고했습니다. 해당 제출서는 Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC 및 Kenneth Griffin을 포함한 공동 Schedule 13G입니다. 개별 법인별 보유량은 570주에서 Griffin 씨의 697,997주까지 다양합니다. 그룹들은 단독 의결권이나 처분권이 없음을 보고했으며; 보고된 모든 의결권 및 처분권은 공유됩니다. 비율은 2025년 6월 30일 기준 발행주식 13,688,405주를 기준으로 산정되었습니다.
Des entités liées à Citadel et Kenneth Griffin déclarent la propriété bénéficiaire d'actions ordinaires de Semler Scientific (SMLR) totalisant environ 697 427 actions, soit 5,1% de la catégorie. Le dépôt est un Schedule 13G conjoint couvrant Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC et Kenneth Griffin. Les détentions par entité vont de 570 actions à 697 997 actions pour M. Griffin. Les groupes déclarent ne détenir aucun pouvoir de vote ou de disposition exclusif ; tous les pouvoirs de vote et de disposition déclarés sont partagés. Les pourcentages sont calculés sur 13 688 405 actions en circulation au 30 juin 2025.
Citadel-nahe Einheiten und Kenneth Griffin melden wirtschaftliches Eigentum an Semler Scientific (SMLR) Stammaktien in Höhe von insgesamt rund 697.427 Aktien, was 5,1% der Klasse entspricht. Die Meldung ist ein gemeinsames Schedule 13G, das Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC und Kenneth Griffin umfasst. Die Bestände je Einheit reichen von 570 Aktien bis zu 697.997 Aktien bei Herrn Griffin. Die Gruppen geben an, keine alleinige Stimm- oder Verfügungsmacht zu haben; alle gemeldeten Stimm- und Verfügungsmachten sind geteilt. Die Prozentsätze wurden auf Grundlage von 13.688.405 ausstehenden Aktien zum 30. Juni 2025 berechnet.